BayCare Health System Site Map Social Media Contact Us
Morton Plant Mease  
Find a Doctor Classes & Events Pay My Bill Financial Assistance Policy Donate Get E-Newsletter
Services About Us Locations News Health Tools and Articles Careers Contact Us
 
Decrease (-) Restore Default Increase (+) font size
PrintEmail
Bookmark and Share
Back

News

Print This Page Print This Page    Email this to a Friend Email this to a Friend
2008 Press Releases
Morton Plant Mease Health Care Cardiologists Among First to Use New Minimally Invasive Treatment for Heart Disease
02/11/2008

FDA Approves Endeavor Drug-Eluting Stent

CLEARWATER, Fla., (February 11, 2008) - A minimally invasive alternative to open-heart bypass surgery, the Endeavor® Zotarolimus-Eluting Coronary Stent System is providing a new tool for Morton Plant Mease interventional cardiologists in the fight against heart disease. Recently approved for use by the U.S. Food and Drug Administration for the treatment of coronary artery disease – the most common type of heart disease - Morton Plant Mease cardiologists are among the first physicians in the nation to treat patients with the newly approved drug-eluting stent.

“Morton Plant Mease often has been on the leading edge of providing the community with the latest in heart care treatments. We were the first health care system in the Tampa Bay area to use drug-eluting stents. Endeavor is another first for us that offers physicians and patients an exciting, new option when treating heart disease,” said Philip K. Beauchamp, FACHE, president and chief executive officer, Morton Plant Mease Health Care.

The Endeavor stent is a tiny wire mesh tube used to prop open coronary arteries that have been cleared of blockages to restore blood flow to the heart muscle. The drug-eluting stent delivers medication to the artery wall to reduce the chance that the artery will narrow again and require a repeat procedure. Endeavor is the first new drug-eluting stent approved by the U.S. Food and Drug Administration since 2004.

“Coronary artery disease is the leading cause of death for both men and women in the United States. Navigating and opening narrowed blood vessels that encircle the heart is a delicate medical procedure. The Endeavor stent provides cardiologists with another tool for accessing and treating those vessels safely and effectively,” said Bernardo Stein, M.D., interventional cardiologist, Morton Plant Mease Health Care.

According to Medtronic, Inc. the manufacturer of Endeavor, seven clinical research studies were done to test for safety, effectiveness and deliverability of the stent. Clinical research data on Endeavor encompasses the largest, most wide-ranging patient population submitted to the FDA in support of a drug-eluting stent, including more than 4,100 patients, followed for as long as four years. Morton Plant Mease interventional cardiologists Patrick Cambier, M.D., and Douglas Spriggs, M.D., were at the forefront of clinical trials for Endeavor at Morton Plant Mease hospitals.

The FDA approved Endeavor for use in the treatment of coronary artery disease on February, 1, 2008. As a condition of FDA approval, Medtronic will continue to study the effectiveness of Endeavor by ensuring that at least 5,000 patients are followed to a minimum of five years.

All of the BayCare Health System hospitals that offer interventional cardiology will be using the Endeavor stent including Morton Plant, Clearwater; Mease Countryside, Safety Harbor; St. Joseph’s, Tampa; St. Anthony’s, St. Petersburg.

Morton Plant Mease Heart Program Firsts:

  • First in Tampa Bay area to place drug-coated stents
  • First in Tampa Bay area to perform minimally invasive direct coronary artery bypass
  • First use of human donor valves in aortic valve replacement
  • First in Pinellas County to perform coronary angioplasty and valvuloplasty
  • First in Pinellas County to have an electrophysiology program for the diagnosis and treatment of arrhythmias
  • First in Pinellas County to perform cardiac ablation procedures
  • First in Pinellas County to perform coronary angioplasty via the radial artery
  • First cardiac surgery program in the Tampa Bay area to use concept of “universal beds”

About Morton Plant Mease Health Care:

Nationally recognized for health care excellence, Morton Plant Mease Health Care is dedicated to providing community owned health care services that set the standard for high-quality, compassionate care. Morton Plant Mease Health Care is comprised of the following hospitals – Morton Plant, Clearwater; Mease Dunedin, Dunedin; Mease Countryside, Safety Harbor and Morton Plant North Bay, New Port Richey.

Contact: Beth Hardy (727) 298-6199 Phone, (727) 402-8113 Pager or Amy Morrow (727) 461-8538 Phone, (727) 402-5975 Pager

###